Biopharmaceutical Market 2019 Global Trends, Market Share, Industry Size, Growth, Opportunities and Forecast to 2024
Jul 2, 2019
WiseGuyReports.com adds “Biopharmaceutical Market 2019 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2024” reports to its database
Pune, India - July 1, 2019 /MarketersMedia/ —
Summary
WiseGuyReports.com adds “Biopharmaceutical Market 2019 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2024” reports to its database.
This report provides in depth study of “Biopharmaceutical Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Biopharmaceutical Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.
A biopharmaceutical, also known as a biologic (al) medical product, biological, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semi synthesized from biological sources. Different from totally synthesized pharmaceuticals, they include vaccines, blood, blood components, allergenic, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living cells used in cell therapy. Biologics can be composed of sugars, proteins, or nucleic acids or complex combinations of these substances, or may be living cells or tissues. They (or their precursors or components) are isolated from living sources—human, animal, plant, fungal, or microbial.
North America has the highest market share for the estimated period owing to presence of sophisticated healthcare infrastructure, growing geriatric population base and increased healthcare expenditure in the region. Asia Pacific is expected to register the highest growth rate for the forecasted period mainly due to presence of unmet market opportunities in the region.
This report focuses on the global Biopharmaceutical status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Biopharmaceutical development in United States, Europe and China.
The key players covered in this study
Roche
Amgen
AbbVie
Sanofi-Aventis
Johnson & Johnson
Pfizer
Novo Nordisk
Eli Lilly
Novartis
Merck
Request a Free Sample Report @ https://www.wiseguyreports.com/sample-request/4220210-global-biopharmaceutical-market-size-status-and-forecast-2019-2025
Market segment by Type, the product can be split into
Monoclonal Antibodies
Interferon
Erythropoietin
Insulin
Other
Market segment by Application, split into
Tumor
Diabetes
Cardiovascular
Hemophilia
Other
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Biopharmaceutical status, future forecast, growth opportunity, key market and key players.
To present the Biopharmaceutical development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Biopharmaceutical are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
At Any Query @ https://www.wiseguyreports.com/enquiry/4220210-global-biopharmaceutical-market-size-status-and-forecast-2019-2025
Major Key Points in Table of Content
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Biopharmaceutical Market Size Growth Rate by Type (2014-2025)
1.4.2 Monoclonal Antibodies
1.4.3 Interferon
1.4.4 Erythropoietin
1.4.5 Insulin
1.4.6 Other
1.5 Market by Application
1.5.1 Global Biopharmaceutical Market Share by Application (2014-2025)
1.5.2 Tumor
1.5.3 Diabetes
1.5.4 Cardiovascular
1.5.5 Hemophilia
1.5.6 Other
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Biopharmaceutical Market Size
2.2 Biopharmaceutical Growth Trends by Regions
2.2.1 Biopharmaceutical Market Size by Regions (2014-2025)
2.2.2 Biopharmaceutical Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
…..
12 International Players Profiles
12.1 Roche
12.1.1 Roche Company Details
12.1.2 Company Description and Business Overview
12.1.3 Biopharmaceutical Introduction
12.1.4 Roche Revenue in Biopharmaceutical Business (2014-2019)
12.1.5 Roche Recent Development
12.2 Amgen
12.2.1 Amgen Company Details
12.2.2 Company Description and Business Overview
12.2.3 Biopharmaceutical Introduction
12.2.4 Amgen Revenue in Biopharmaceutical Business (2014-2019)
12.2.5 Amgen Recent Development
12.3 AbbVie
12.3.1 AbbVie Company Details
12.3.2 Company Description and Business Overview
12.3.3 Biopharmaceutical Introduction
12.3.4 AbbVie Revenue in Biopharmaceutical Business (2014-2019)
12.3.5 AbbVie Recent Development
12.4 Sanofi-Aventis
12.4.1 Sanofi-Aventis Company Details
12.4.2 Company Description and Business Overview
12.4.3 Biopharmaceutical Introduction
12.4.4 Sanofi-Aventis Revenue in Biopharmaceutical Business (2014-2019)
12.4.5 Sanofi-Aventis Recent Development
12.5 Johnson & Johnson
12.5.1 Johnson & Johnson Company Details
12.5.2 Company Description and Business Overview
12.5.3 Biopharmaceutical Introduction
12.5.4 Johnson & Johnson Revenue in Biopharmaceutical Business (2014-2019)
12.5.5 Johnson & Johnson Recent Development
12.6 Pfizer
12.6.1 Pfizer Company Details
12.6.2 Company Description and Business Overview
12.6.3 Biopharmaceutical Introduction
12.6.4 Pfizer Revenue in Biopharmaceutical Business (2014-2019)
12.6.5 Pfizer Recent Development
12.7 Novo Nordisk
12.7.1 Novo Nordisk Company Details
12.7.2 Company Description and Business Overview
12.7.3 Biopharmaceutical Introduction
12.7.4 Novo Nordisk Revenue in Biopharmaceutical Business (2014-2019)
12.7.5 Novo Nordisk Recent Development
12.8 Eli Lilly
12.8.1 Eli Lilly Company Details
12.8.2 Company Description and Business Overview
12.8.3 Biopharmaceutical Introduction
12.8.4 Eli Lilly Revenue in Biopharmaceutical Business (2014-2019)
12.8.5 Eli Lilly Recent Development
12.9 Novartis
12.9.1 Novartis Company Details
12.9.2 Company Description and Business Overview
12.9.3 Biopharmaceutical Introduction
12.9.4 Novartis Revenue in Biopharmaceutical Business (2014-2019)
12.9.5 Novartis Recent Development
12.10 Merck
12.10.1 Merck Company Details
12.10.2 Company Description and Business Overview
12.10.3 Biopharmaceutical Introduction
12.10.4 Merck Revenue in Biopharmaceutical Business (2014-2019)
12.10.5 Merck Recent Development
Continued....
Contact Us: [email protected]
Ph: +1-646-845-9349 (US); Ph: +44 208 133 9349 (UK)
Contact Info:
Name: NORAH TRENT
Email: Send Email
Organization: WISE GUY RESEARCH CONSULTANTS PVT LTD
Address: Office No. 528, Amanora Chambers, Magarpatta Road, Hadapsar, Pune - 411028
Phone: +1-646-845-9349 (US), +44 208 133 9349 (UK)
Website: https://www.wiseguyreports.com/sample-request/4220210-global-biopharmaceutical-market-size-status-and-forecast-2019-2025
Source: MarketersMedia
Release ID: 88891711
More News
Anthropic Pursues IPO Despite Its A.I. Safety Warnings
The company is expected to reach $100 billion in annualized revenue this year, even as chief executive Dario Amodei calls for slowing down development of some advanced A.I. models.
Native American Tribe Teams Up With Kalshi on New Prediction Market
The Tunica-Biloxi of Louisiana plan to release a platform that uses infrastructure by Kalshi, the industry leader. Other tribes have taken aim at the company.
Trump Promotes Program to Reduce Medicaid Drug Prices
Ahead of the midterm elections, the president said that all states had opted in to an effort to align Medicaid’s prices for medicines with those in other wealthy countries.
Who Is Howard Buffett, the New Berkshire Hathaway Chairman?
Mr. Buffett, 71, is succeeding his father, Warren, but will not be running the company’s day-to-day operations.
Uber to Pay $40 Million to Parents of Woman Fatally Hit by Car
Emily Normandin-Parker, 23, was struck and killed on a California freeway after an Uber driver ordered her and a friend out of his car in August 2023.
S.E.C. Seeks to End Shareholder Proposals Process Commonly Used by Activists
Activists have often used the rule to push for changes in companies’ governance and environmental and social policies.
'We simply don't know' - JP Morgan struggling to forecast oil prices due to Trump's war with Iran
The bank said it "assumed" there would be economic red lines, like oil at $100 a barrel, that the US would be unwilling the cross.
Warren Buffett steps down after six decades at Berkshire - 'Father Time always wins'
Since taking control in 1965, Buffett grew a struggling textile mill into a global conglomerate.
Ryanair boss Michael O'Leary apologises over 'high-fare rapists' remarks
O'Leary described his choice of language as "careless" and said "it won't happen again".
What Set Off the Rise in Interest Rates? Mainly, the Iran War.
The Federal Reserve is trying to catch up with the leap in bond rates as the Middle East conflict unnerves world markets.
The A.I. Industry’s New Worry: ‘Liability Exposure’
The prospect of artificial intelligence tools being used to do significant harm presents the companies and their leaders with a legal challenge.
Disney Hires Its First CTO Amid Industry Push to Embrace A.I.
Karandeep Anand, an expert in building artificial intelligence and consumer technology products, will become Disney’s first chief technology officer.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.